Sarepta therapeutics stock

See also: Sarepta therapeuticsSarepta therapeutics.comSarepta therapeutics 10kSarepta therapeutics arkSarepta therapeutics ceoSarepta therapeutics fda

Keywords Suggestions

Sarepta therapeutics stock

Sarepta therapeutics stock drop

Sarepta therapeutics stock news

Sarepta therapeutics stock chart

Sarepta therapeutics stock quote

Sarepta therapeutics stock split

Sarepta therapeutics stock price

Sarepta therapeutics stock symbol

Sarepta therapeutics stock ticker

Sarepta therapeutics stock forecast

Sarepta therapeutics stock market cap

Sarepta therapeutics stock price today

( Please select at least 2 keywords )

Related websites

Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, …

  • Find the latest Sarepta Therapeutics, Inc
  • (SRPT) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com   DA: 17 PA: 11 MOZ Rank: 29

SRPT Stock Price Sarepta Therapeutics Inc. Stock Quote …

  • SRPT | Complete Sarepta Therapeutics Inc
  • View real-time stock prices and stock quotes for a full financial overview.

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 42

SRPT Sarepta Therapeutics Inc. — Stock Price and …

  • NASDAQ Updated Oct 15, 2021 11:55 PM SRPT 84.19 1.19 (1.43%)

Stocktwits.com   DA: 14 PA: 12 MOZ Rank: 29

SRPT -- Is Its Stock Price A Worthy Investment

  • Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; only 12.96% of US stocks have a lower such ratio
  • SRPT's price/sales ratio is 12.66; that's higher than the …

Stocknews.com   DA: 13 PA: 12 MOZ Rank: 29

What’s Next For Sarepta Stock After A 12% Fall

Sarepta Therapeutics stock rose 3.7% the last twenty-one trading days (one month), compared to broader market (S&P500) decline of 2.0%; A change of 3.7% or more over twenty-one trading days is a

Forbes.com   DA: 14 PA: 50 MOZ Rank: 69

Sarepta Therapeutics Announces Pricing of $500 Million …

  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 73

Why Sarepta Therapeutics Tumbled Today The Motley Fool

  • On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ:SRPT) stock fell by over 12% today
  • Investors were displeased with a company update about its

Fool.com   DA: 12 PA: 50 MOZ Rank: 69

Biopharmaceutical Company for Rare Diseases

Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021 10/12/2021 Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock

Sarepta.com   DA: 15 PA: 15 MOZ Rank: 38

October 29th Options Now Available For Sarepta …

  • Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the October 29th expiration
  • At Stock Options Channel, our YieldBoost formula has looked up and down

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 73

Sarepta Therapeutics, Inc.

  • SRPT investment & stock information
  • Get the latest Sarepta Therapeutics, Inc
  • SRPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Zacks.com   DA: 13 PA: 17 MOZ Rank: 40

Sarepta Therapeutics Inc. Stock Overview (U.S.: Nasdaq)

  • Complete Sarepta Therapeutics Inc
  • View real-time SRPT stock price and news, along with industry-best analysis.

Barrons.com   DA: 15 PA: 24 MOZ Rank: 50

Sarepta Therapeutics Stock Forecast

  • The Sarepta Therapeutics stock price fell by -0.26% on the last day (Thursday, 14th Oct 2021) from $83.22 to $83.00
  • and has now fallen 3 days in a row.During the day the stock fluctuated 4.23% from a day low at $82.27 to a day high of $85.75.The price has been going up and down for this period, and there has been a -10.25% loss for the last 2 weeks.

Stockinvest.us   DA: 14 PA: 11 MOZ Rank: 37

Sarepta Therapeutics Announces Proposed $500,000,000 Public …

  • 12, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (Nasdaq:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market and other conditions, $500,000,000 in shares of its common stock in an underwritten public offering.

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 92

Sarepta Therapeutics, Inc. (SRPT) Stock Price Today, Quote & …

  • A high-level overview of Sarepta Therapeutics, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 42

Buy or Sell Sarepta Therapeutics Inc. (SRPT) Stock Now Don’t Try …

  • (NASDAQ:SRPT) went down by -3.53% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected -11.03% of loss in the last five trading sessions
  • Press Release reported 12 hours ago that Lysogene Announces a Presenta

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 79

SRPT Price Target, Analyst Ratings & Predictions (Sarepta …

  • According to the issued ratings of 21 analysts in the last year, the consensus rating for Sarepta Therapeutics stock is Buy based on the current 9 hold ratings and 12 buy ratings for SRPT
  • The average twelve-month price target for Sarepta Therapeutics is $132.65 with a high price target of $215.00 and a low price target of $75.00

Marketbeat.com   DA: 18 PA: 33 MOZ Rank: 67

SRPT Sarepta Therapeutics Inc. Annual Income Statement

  • Annual stock financials by MarketWatch
  • View the latest SRPT financial statements, income statements and financial ratios.

Marketwatch.com   DA: 19 PA: 32 MOZ Rank: 68

$SRPT: Investors will love the forecast for Sarepta Therapeutics Inc …

  • The number of outstanding shares for Sarepta Therapeutics Inc is 79845000
  • Now that you know more about Sarepta Therapeutics Inc stands, let’s learn more about the future of the company
  • As an investor, you can get an idea of where the stock is trending by the forecast and beta
  • Beta is calculated using regression analysis.

Wallstreetfacts.com   DA: 19 PA: 50 MOZ Rank: 87

SRPT Sarepta Therapeutics Inc. SEC Filings MarketWatch

  • 13, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an

Marketwatch.com   DA: 19 PA: 43 MOZ Rank: 81

Sarepta Therapeutics Announces Pricing of $500 Million Public …

  • Sarepta Therapeutics Announces Pricing of $500 Million Public Offering of Common Stock
  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 91

Sarepta Therapeutics Stock Price

  • Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock Globe Newswire - Tue Oct 12, 3:01PM CDT CAMBRIDGE, Mass., Oct
  • 12, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (Nasdaq:SRPT), the leader in precision genetic medicine for rare diseases,

Barchart.com   DA: 16 PA: 19 MOZ Rank: 56

Buy shares of Sarepta Therapeutics Inc stock (SRPT)

  • How to buy Sarepta Therapeutics Inc stock on Stash
  • Enter the amount you'd like to invest in Sarepta Therapeutics Inc stock, then proceed to checkout
  • Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Stash.com   DA: 13 PA: 50 MOZ Rank: 85

Sarepta Therapeutics, Inc. (SRPT) Stock Price, Quote & News

How Does Sarepta's Stock Performance In The Current Crisis Compare With That In 2008? We believe that Sarepta Therapeutics stock, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, is a good buying

Stockanalysis.com   DA: 17 PA: 13 MOZ Rank: 53

SRPT: Sarepta Therapeutics Inc

Get Sarepta Therapeutics Inc (SRPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 48

SRPT Sarepta Therapeutics, Inc. Stock Quote

  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases
  • The company offers EXONDYS 51 injection to treat duchenne muscular dystrophy (DMD) in patients who have a

Finviz.com   DA: 10 PA: 11 MOZ Rank: 46

Analysts Are Bullish on These Healthcare Stocks: Sarepta …

  • Sarepta Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $117.64, representing a 22.3% upside
  • In a report issued on September 27, Robert W
  • Baird also maintained a Buy rating on the stock with a $110.00 price target.

Analystratings.com   DA: 22 PA: 50 MOZ Rank: 98

Expert Ratings For Sarepta Therapeutics Markets Insider

  • In the last 3 months, 6 analysts have offered 12-month price targets for Sarepta Therapeutics
  • The company has an average price target of $95.33 with a high of $125.00 and a low of $75.00

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 23

SRPT SEC Filings & 10K Form (Sarepta Therapeutics)

  • Sarepta Therapeutics (Filer) Form 10-Q
  • General form for quarterly reports under Section 13 or 15 (d) 06/28/2021
  • INGRAM DOUGLAS S (Reporting) Sarepta Therapeutics (Issuer) Form 4
  • Statement of changes in beneficial ownership of securities.

Marketbeat.com   DA: 18 PA: 32 MOZ Rank: 78

SRPT Stock Forecast, Price Targets and Analysts Predictions

  • Based on 13 Wall Street analysts offering 12 month price targets for Sarepta Therapeutics in the last 3 months
  • The average price target is $116.27 with a high forecast of $166.00 and a low forecast of $75.00
  • The average price target represents a 47.98% change from the last price of $78.57

Tipranks.com   DA: 16 PA: 21 MOZ Rank: 66

Medical sector's Sarepta Therapeutics (NASDAQ:SRPT)'s Hold …

  • Sarepta Therapeutics (NASDAQ:SRPT)‘s stock had its Hold rating Reiterated by analysts at Berenberg Bank – 4 stars in a research report issued to clients and investors
  • A price-to-earnings ratio of #N/A, market cap of 6.7B and a beta of 1.42
  • Sarepta Therapeutics has a twelve month low $65.30 of and a twelve month high of $181.83.

Stockmarketdaily.co   DA: 19 PA: 50 MOZ Rank: 99

Is Sarepta Therapeutics Inc (SRPT) Stock a Smart Value Tuesday

  • Sarepta Therapeutics Inc (SRPT) stock is down -0.98% while the S&P 500 has gained 0.57% as of 2:49 PM on Tuesday, Oct 19
  • SRPT is lower by -$0.80 from the previous closing price of $81.22 on volume of 369,487 shares
  • Over the past year the S&P 500 is higher by 31.67% while SRPT is lower by -42.88%.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 19

SRPT Stock News SAREPTA THERAPEUTICS Stock Price Today …

SRPT: Get the latest Sarepta Therapeutics stock price and detailed information including SRPT news, historical charts and realtime prices.

Markets.businessinsider.com   DA: 27 PA: 18 MOZ Rank: 77

Q3 2021 EPS Estimates for Sarepta Therapeutics, Inc. Boosted by …

  • Sarepta Therapeutics has a 1 year low of $65.30 and a 1 year high of $181.83
  • The company has a debt-to-equity ratio of 2.25, a current ratio of 5.33 and a quick ratio of 4.70
  • The stock's fifty day moving average price is $83.83 and its 200-day moving average price is $77.52
  • Sarepta Therapeutics (NASDAQ:SRPT) last released its quarterly

Marketbeat.com   DA: 18 PA: 50 MOZ Rank: 17

Sarepta Therapeutics, Inc. (SRPT) Dividend History, Dates & Yield …

5 days ago - Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quar-ter Ended September 30, 2021 - GlobeNewsWire5 days ago - Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock - GlobeNewsWire6 days ago - Sarepta's Duchenne Gene Therapy Shows Sustained Functional …

Stockanalysis.com   DA: 17 PA: 22 MOZ Rank: 73

Sarepta Therapeutics

  • Sarepta Therapeutics has raised a total of $880M in funding over 5 rounds
  • Their latest funding was raised on Feb 14, 2020 from a Post-IPO Equity round
  • Sarepta Therapeutics is registered under the ticker NASDAQ:SRPT

Crunchbase.com   DA: 18 PA: 50 MOZ Rank: 15

SRPT Stock Quote of Sarepta Therapeutics

  • Sarepta Therapeutics (SRPT) stock is sinking after the company's late Tuesday announcement that it was offering a $350 million stock ofering
  • Why NOW Is the Time to Buy Gene Therapy Stocks By

Investorplace.com   DA: 17 PA: 31 MOZ Rank: 84

How Does Sarepta’s Stock Performance In The Current Crisis …

We believe that Sarepta Therapeutics stock, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, is a good

Forbes.com   DA: 14 PA: 50 MOZ Rank: 13

Sarepta Therapeutics (NASDAQ:SRPT) Stock Price, News, Charts

Sarepta Therapeutics (NASDAQ: SRPT) stock price, news, charts, stock research, profile.

Benzinga.com   DA: 16 PA: 11 MOZ Rank: 65

The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Editas …

  • Click to get this free report Beam Therapeutics Inc
  • (BEAM): Free Stock Analysis Report Sarepta Therapeutics, Inc
  • (SRPT): Free Stock Analysis Report Editas Medicine, Inc

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 11

Premarket Movers: dLocal, TaskUs, Sarepta Therapeutics Barron's

  • 20 hours ago · With U.S
  • stock markets set to open in two hours, Sarepta Therapeutics (SRPT) was up 4.7% in pre-market trading, and NeoGenomics (NEO) was up 4.4%
  • Marqeta (MQ), Dover Corp (DOV), and Travelers

Barrons.com   DA: 15 PA: 50 MOZ Rank: 10

Sarepta Therapeutics Inc (SRPT) Quote

  • Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases
  • It targets a broad range of diseases while focusing on the rapid development of its drug

Morningstar.com   DA: 19 PA: 23 MOZ Rank: 83

Do Analysts Agree Monday on Sarepta Therapeutics Inc (SRPT) …

  • Sarepta Therapeutics Inc (SRPT) stock is down -4.94% while the S&P 500 has risen 0.47% as of 10:42 AM on Monday, Oct 11
  • SRPT is down -$4.91 from the previous closing price of $99.42 on volume of 788,801 shares
  • Over the past year the S&P 500 has gained 24.83% while SRPT is down -33.85%
  • SRPT lost -$8.03 per share the over the last 12 months.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 8

Sarepta Therapeutics

  • Stock split history for Sarepta Therapeutics since 1997
  • Prices shown are actual historical values and are not adjusted for either splits or dividends
  • Please see the "Historical Prices" tab for adjusted price values.

Macrotrends.net   DA: 19 PA: 50 MOZ Rank: 7

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Shhjfz.com 232 days leftTurnCommerce, Inc. DBA NameBright.comDomain Name Services
Szaferman.com 313 days leftGoDaddy.com, LLCGoogle LLC
Zngb.com 148 days leftXiamen 35.Com Technology Co., Ltd.Chengdu west dimension digital technology Co., LTD
Communityadvantagepay.com 259 days leftGandi SASCloudflare, Inc.
Nxstage.com 161 days leftCSC Corporate Domains, Inc.Amazon Technologies Inc.
Dzilth.net3 years, 233 days leftGoDaddy.com, LLCDomain Name Services
Fandom.com1 year, 354 days leftTucows Domains Inc.Fastly
Amazonaws.com2 years, 87 days leftMarkMonitor Inc.Amazon Technologies Inc.
Blowmepov.com2 years, 201 days leftWild West Domains, LLCiWeb Technologies Inc.
Wedshops.com 95 days leftGoDaddy.com, LLCGoDaddy.com, LLC

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]